New Patient Access – Biosimilar Boom Research Now Available
Specialty Pharmacies and the Biosimilar Boom Understanding the various revenue streams of Specialty Pharmacy (SP) network partners is the key to identifying how biopharma can best incentivize SPs. A critical success factor for biosimilars is the ability to deploy unique contracting strategies that will not affect Average Sale Price (ASP). In the latest research from […]